Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

µÎ°³°­³» ¼ö¸·Á¾¿¡¼­ Áõ½Ä¼¼Æ÷ ÇÙÇ׿ø°ú ÀÓ»óº´¸®ÇÐÀû Ư¡ÀÇ ºñ±³¿¬±¸ Comparative Study of the Proliferating Cell Nuclear Antigen and Clinicopathological Features in Intracranial Meningiomas

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1997³â 26±Ç 1È£ p.48 ~ 53
±èÃæÇö, ÇÏ¿µÀÏ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÃæÇö (  ) 
ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç

ÇÏ¿µÀÏ (  ) 
Áö¹æ°ø»ç °­³²º´¿ø ½Å°æ¿Ü°ú

Abstract

¼­ ·Ð
³ú¼ö¸·Á¾Àº µÎ°³°­³»¿¡ ¹ß»ýµÇ´Â ¿ø¹ß¼º Á¾¾çÀÇ ¾à 20%¸¦ Â÷ÁöÇÏ´Â Á¾¾çÀÌ¸ç ´ëºÎºÐÀº
¾ç¼ºÁ¾¾çÀÌ´Ù. ±×·¯³ª ÀϺΠ³ú¼ö¸·Á¾Àº ¾Ç¼ºÁ¾¾çÀ¸·Î ÁÖº¯ÀÇ ³úÁ¶Á÷À̳ª µÎ°³°ñ µîÀ» ħ½À
ÇÏ¸ç ±Þ¼ÓÈ÷ ÀÚ¶ó±âµµÇÏ¸ç ¼ö¼úÈÄ Àç¹ßÀ» Çϱ⵵ ÇÑ´Ù. ¶ÇÇÑ Á¶Á÷ÇÐÀûÀ¸·Î ¾ç¼ºÀÎ Á¾¾çÀ»
À°¾ÈÀûÀ¸·Î ¿ÏÀüÈ÷ ÀýÁ¦ÇÏ´õ¶óµµ 2.3¡­30%¿¡¼­´Â Àç¹ßÀ» ÇÏ°í Àִµ¥ ÀÌ´Â Á¾¾çÀÇ ¼¼Æ÷Áõ
½Ä·Â°ú ¹ÐÁ¢ÇÑ ¿¬°üÀÌ ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. µû¶ó¼­ Á¾¾çÀÇ »ý¹°ÇÐÀû ¼º»óÀ» ÆľÇÇÔÀ¸
·Î¼­ Á¾¾çÀÇ Áõ½Ä·Â È®ÀÎ»Ó ¸¸ ¾Æ´Ï¶ó ÀÓ»óÀûÀ¸·Î ȯÀÚÀÇ ¿¹ÈÄ ÃßÁ¤À» Æ÷ÇÔÇÑ ¸¹Àº Á¤º¸¸¦
Á¦°ø¹ÞÀ» ¼ö ÀÖ´Ù.
Á¾¾çÀÇ Áõ½Ä·ÂÀ» ÃøÁ¤ÇÏ´Â ¹æ¹ýÀº ¿©·¯ Á¾·ù°¡ ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¹æ¹ýµéÀÌ °øÅëÀûÀ¸
·Î °®Ãç¾ßÇÒ Á¶°ÇÀ¸·Î´Â ¿ì¼± ±â¼úÀûÀ¸·Î ½¬¿ö¾ßÇÏ¸ç °æÁ¦ÀûÀ̾î¾ß ÇÏ°í, ¶ÇÇÑ ÀçÇö¼ºÀÌ ³ô
¾Æ¾ßÇÑ´Ù. ±âÁ¸¿¡ °³¹ßµÇ¾îÀÖ´Â ¼¼Æ÷Áõ½Ä·Â ÃøÁ¤¹æ¹ýÀº ´ëºÎºÐ ¹æ»ç¼± µ¿À§¿ø¼Ò·Î Àüóġ¸¦
Çϰųª Á¾¾çÇ¥ÁöÀÚÀÇ Ç׿ø¼ºÀÌ ¾ø¾îÁöÁö ¾Êµµ·Ï Ưº°ÇÑ ±â¼úÀÌ ¿äÇϳª Áõ½Ä¼¼Æ÷ÇÙÇ׿ø(ÀÌÇÏ
PCNA·Î ¾àÇÔ)ÃøÁ¤Àº Àüóġ°¡ ÇÊ¿ä¾øÀ¸¸ç ÆĶóÇÉ Æ÷¸ÅÁ¶Á÷À» ÀÌ¿ëÇÏ¿© ÈÄÇâÀû ¿¬±¸°¡ °¡
´ÉÇϹǷΠÀ̸¦ ÀÌ¿ëÇÑ ¸¹Àº ¿¬±¸°¡ ½ÃÇàµÇ°í ÀÖ´Ù.
ÇÑÆí ³ú¼ö¸·Á¾Àº È£¸£¸ó ÀÇÁ¸¼ºÀÌ ÀÖ´Â Á¾¾çÀ¸·Î ƯÈ÷ ÇÁ·ÎÁ¦½ºÅ×·Ð ¼ö¿ë±â (ÀÌÇÏ PgR·Î
¾àÇÔ)°¡ ¾à 53%¿¡¼­ ¹ßÇöµÇ¸ç ÀÌ·¯ÇÑ ¼ö¿ë±â´Â ¾Ç¼ºµµ°¡ ³ôÀº Á¾¾çº¸´Ù´Â ¾ç¼ºÁ¾¾ç¿¡¼­ Èç
ÇÏ°Ô °ËÃâµÈ´Ù. ¶ÇÇÑ PgR¾ç¼ºÀÎ ¼ö¸·Á¾Àº Á¶Á÷ÇÐÀûÀ¸·Î ¼¶À¯Çüº¸´Ù´Â ÀÌÇàÇü¿¡¼­ ¹ß»ýÀ§Ä¡
»ó ´ë³ú±Ã¸¢ºÎº¸´Ù´Â ³ú¿¡¼­ ´õ ÈçÈ÷ ¹ß°ßµÈ´Ù. ÀÌ¿Í °°Àº PgR°¡ ¾ç¼ºÀÎ Á¾¾çÀº À½¼ºÀÎ °æ
¿ìº¸´Ùµµ Ki-67 labellingÁö¼ö°¡ ³·Àº °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. µû¶ó¼­ ³ú¼ö¸·Á¾ÀÇ Áõ½Ä·Â°ú ÀÓ»ó
º´¸®ÇÐÀû Ư¡°£¿¡µµ ÀÓ»óÀûÀ¸·Î À¯¿ëÇÑ °ü°è°¡ ÀÖÀ» °ÍÀ¸·Î »ý°¢µÈ´Ù.
ÀúÀÚµéÀº ³ú¼ö¸·Á¾ÀÇ PCNAÃøÁ¤À» ÀÌ¿ëÇÑ ¼¼Æ÷Áõ½Ä·Â°ú Á¾¾çÀÇ Áø´Ü ½Ã ȯÀÚÀÇ ¿¬·É°ú
¼ºº°, ¼úÀü ³úÀü»êÈ­ ´ÜÃþÃÔ¿µ ³úÀÚ±â°ø¸íÃÔ¿µ»ó Á¾¾çÀÇ Å©±â ¹× ¹ß»ýÀ§Ä¡, Á¶Á÷Çü ¹× À¯¹«
µî°úÀÇ °ü°è¸¦ ºñ±³ ºÐ¼®ÇÏ¿´±â¿¡ º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
#ÃÊ·Ï#
The PC10, a monoclonal antibody(mAb) to proliferating cell nuclear antigen(PCNA), is
known to show immunoreactively in paraffin embedded tissue. The authors present the
relation between PCNA expression and clinicopathological features such as patient's age
and sex, tumor size and location, histological types, and recurrence in 18 intracranial
meningiomas.
PCNA scores were obtained by immunostaining of the paraffin embedded surgical
specimens using a streptoavidin/peroxidase method with PC 10 mAb, which recognized
an epitope on the PCNA. Univariate analysis showed that high PC 10 scores were
associated with old age(¡Ã50 years old), male, recurrent tumor and meningothelial tended
to be higher than that of hemispheric meningioma(p<0.05). The staining intensity of
PCNA was markedly increased in basal menigiomas.
It is suggested that the proliferative potential is higher in basal meningiomas than un
hemispheric meningiomas, however, the number of patients in this study is too small to
draw a statistically conclusion.

Å°¿öµå

Meningioma; PCNA; Clinicopathological features.;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS